Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes

We previously reported intense pial cerebral collateralization and arteriogenesis in a mild and lean model of type 2 diabetes (T2D), Goto-Kakizaki (GK) rats. Increased cerebral neovascularization differed regionally and was associated with poor vessel wall maturity. Building upon these findings, the goals of this study were to determine whether a) glycemic control prevents this erratic cerebral neovascularization in the GK model, and b) this pathological neovascularization pattern occurs in Leprdb/db model, which is the most commonly used model of T2D for studies involving cerebral complications of diabetes. Vascular volume, surface area and structural parameters including microvessel/macrovessel ratio, non-FITC (fluorescein) perfusing vessel abundance, vessel tortuosity, and branch density were measured by 3D reconstruction of FITC stained vasculature in GK rats or Leprdb/db mice. GK rats exhibited an increase in all of these parameters, which were prevented by glycemic control with metformin. In Leprdb/db mice, microvascular density was increased but there was no change in nonFITC-perfusing vessels. Increased PA branch density was associated with reduced branch diameter. These results suggest that T2D leads to cerebral neovascularization and remodeling but some structural characteristics of newly formed vessels differ between these models of T2D. The prevention of dysfunctional cerebral neovascularization by early glucose control suggests that hyperglycemia is a mediator of this response.

[1]  A. Ergul,et al.  Angiogenesis: A Harmonized Target for Recovery After Stroke , 2012, Stroke.

[2]  R. Knight,et al.  Cerebral Myogenic Reactivity and Blood Flow in Type 2 Diabetic Rats: Role of Peroxynitrite in Hypoxia-Mediated Loss of Myogenic Tone , 2012, Journal of Pharmacology and Experimental Therapeutics.

[3]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[4]  A. Ergul,et al.  Enhanced Cerebral but Not Peripheral Angiogenesis in the Goto-Kakizaki Model of Type 2 Diabetes Involves VEGF and Peroxynitrite Signaling , 2012, Diabetes.

[5]  M. Graña,et al.  Knowledge management in image-based analysis of blood vessel structures , 2012, Knowledge and Information Systems.

[6]  A. Ergul,et al.  Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  D. Bruemmer,et al.  Intensive glycemic control and cardiovascular disease: an update , 2010, Nature Reviews Cardiology.

[8]  A. Ergul,et al.  Adaptive Cerebral Neovascularization in a Model of Type 2 Diabetes , 2009, Diabetes.

[9]  Laurent Risser,et al.  A 3D-investigation shows that angiogenesis in primate cerebral cortex mainly occurs at capillary level , 2009, International Journal of Developmental Neuroscience.

[10]  A. Dorrance,et al.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  Jefferson C Frisbee,et al.  Obesity and vascular dysfunction. , 2008, Pathophysiology : the official journal of the International Society for Pathophysiology.

[12]  Ralph Müller,et al.  Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF165 in the brain , 2008, NeuroImage.

[13]  A. Favier,et al.  Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. , 2008, Clinical science.

[14]  J. Switzer,et al.  Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes , 2007, BMC neurology.

[15]  J. LaManna,et al.  Physiologic angiodynamics in the brain. , 2007, Antioxidants & redox signaling.

[16]  P. Dockery,et al.  The quantification of vascular beds: a stereological approach. , 2007, Experimental and molecular pathology.

[17]  David Kleinfeld,et al.  Penetrating arterioles are a bottleneck in the perfusion of neocortex , 2007, Proceedings of the National Academy of Sciences.

[18]  J. Argente,et al.  Reduction in the number of astrocytes and their projections is associated with increased synaptic protein density in the hypothalamus of poorly controlled diabetic rats. , 2006, Endocrinology.

[19]  A. Araque.  Astrocyte-neuron signaling in the brain--implications for disease. , 2006, Current opinion in investigational drugs.

[20]  N. Wiernsperger,et al.  Metformin delays the manifestation of diabetes and vascular dysfunction in Goto–Kakizaki rats by reduction of mitochondrial oxidative stress , 2006, Diabetes/metabolism research and reviews.

[21]  M. Murányi,et al.  Streptozotocin-induced diabetes causes astrocyte death after ischemia and reperfusion injury. , 2006, Diabetes.

[22]  G. Kassab.  Scaling laws of vascular trees: of form and function. , 2006, American journal of physiology. Heart and circulatory physiology.

[23]  B. Lévy,et al.  Molecular basis of angiopathy in diabetes mellitus. , 2005, Circulation research.

[24]  Ali Shahrokni,et al.  3-D quantification and visualization of vascular structures from confocal microscopic images using skeletonization and voxel-coding , 2005, Comput. Biol. Medicine.

[25]  L. Pellerin.  How astrocytes feed hungry neurons , 2005, Molecular Neurobiology.

[26]  J. Skyler.  Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes , 2004 .

[27]  A. Lima,et al.  Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice , 2002, Brain Research.

[28]  P. Leuenberger,et al.  Glial reactivity, an early feature of diabetic retinopathy. , 2000, Investigative ophthalmology & visual science.

[29]  J. Skyler.  Targeted glycemic control in type 2 diabetes. , 1998, The Journal of the Florida Medical Association.

[30]  J. Biller,et al.  Cerebrovascular disorders in patients with diabetes mellitus. , 1996, Journal of diabetes and its complications.

[31]  A. McCall.  The Impact of Diabetes on the CNS , 1992, Diabetes.

[32]  R. C. Collins,et al.  Metabolic anatomy of brain: A comparison of regional capillary density, glucose metabolism, and enzyme activities , 1989, The Journal of comparative neurology.

[33]  McCuskey Pa,et al.  In vivo and electron microscopic study of the development of cerebral diabetic microangiography. , 1984 .

[34]  Ralph Müller,et al.  Novel three-dimensional analysis tool for vascular trees indicates complete micro-networks, not single capillaries, as the angiogenic endpoint in mice overexpressing human VEGF(165) in the brain. , 2008, NeuroImage.

[35]  M. C. Angulo,et al.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation , 2003, Nature Neuroscience.

[36]  J. Nyengaard,et al.  Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal region , 2001, Hippocampus.

[37]  T. Secomb,et al.  Mechanics of blood flow in the microcirculation. , 1995, Symposia of the Society for Experimental Biology.

[38]  R. Duckrow,et al.  Regional cerebral blood flow decreases during chronic and acute hyperglycemia. , 1987, Stroke.

[39]  R. McCuskey,et al.  In vivo and electron microscopic study of the development of cerebral diabetic microangiography. , 1984, Microcirculation, endothelium, and lymphatics.